This inventor holds 8 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Repros Therapeutics Inc.. Active years: 2007-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2018
Title: Innovations and Contributions of Inventor Ronald D. Wiehle
Introduction: Ronald D. Wiehle, an accomplished inventor based in Houston, TX, has made significant strides in the field of pharmaceuticals with a focus on treating various disorders. With a portfolio of eight patents, Wiehle's contributions to medical science have paved the way for innovative treatment methods aimed at serious health conditions.
Latest Patents: Among his notable inventions are two groundbreaking patents related to trans-clomiphene metabolites. The first patent, titled "Trans-clomiphene metabolites and uses thereof," discusses the development of substantially pure metabolites of irara-clomiphene. This invention encompasses pharmaceutical compositions that utilize these metabolites to treat a multitude of disorders, including secondary hypogonadism, type 2 diabetes, elevated cholesterol, elevated triglycerides, and various cancers such as prostate and breast cancer. The second patent, "Trans-clomiphene for use in cancer therapy," explores the administration of compositions comprising an antiestrogen, specifically a selective estrogen receptor modulator (SERM) like trans-clomiphene, for combating cancer and associated diseases.
Career Highlights: Ronald D. Wiehle has devoted his career to research and development in the pharmaceutical sector. He has made substantial contributions during his tenure at Repros Therapeutics Inc., where he has been instrumental in advancing innovative treatment options and supporting the company's mission to improve patient health.
Collaborations: Wiehle's work has often involved collaboration with notable colleagues, including Joseph S. Podolski and Kuang T. Hsu. Their combined expertise in pharmaceuticals has enhanced the research and development efforts within their company and has led to the advancement of groundbreaking therapies.
Conclusion: Ronald D. Wiehle stands out as a key inventor in the healthcare field, contributing to the advancement of innovative treatments for significant health challenges. His dedication to research and collaboration with fellow scientists underscores the impact of his work on the lives of patients worldwide. With ongoing projects and a commitment to innovation, Wiehle continues to be a pivotal figure in the pursuit of medical breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile